Ophthalmology

Is Ranibizumab Monotherapy Superior to Combination Therapy in Treating Polypoidal Choroidal Vasculopathy?

August 03, 2020

Article

Ranibizumab, in combination with prompt verteporfin photodynamic therapy, is more effective in treating polypoidal choroidal vasculopathy compared with ranibizumab monotherapy, according to a study published in JAMA Ophthalmology.

Dr Daniel Laroche Discusses Eye-Related Implications, Barriers to Eye Care Amid COVID-19

August 01, 2020

Video

Whether you fit into the older or younger demographic, staying up to date on eye care is key as growing risks of cataracts, glaucoma, diabetic retinopathy, and macular degeneration are leading causes of blindness. Moreover, reducing the structural barriers to eye care, which disproportionately affect blacks and Afro Latinos, can assist in advancing the availability of eye health nationwide, said Daniel Laroche, MD, director of Glaucoma Services and president of Advanced Eye Care of New York.

Can Artificial Intelligence Lead to Personalized Macular Edema Treatment?

July 29, 2020

Article

Using automated spectral-domain optical coherence tomography, researchers found the presence of subretinal fluid (SRF) in individuals with diabetic macular edema (DME) is associated with lower baseline best-corrected visual acuity. The findings of this retrospective study suggest automated quantification of intraretinal fluid and SRF may be an objective approach to assess DME treatment.

Can Anti-VEGF Therapy Benefit Macular Vessel Density?

July 22, 2020

Article

Anti-vascular endothelial growth factor (VEGF) therapy may be useful for patients with retinal nonperfusion, as the treatment does not exacerbate the nonperfusion, according to a study published in JAMA Ophthalmology.

Is Epimacular Brachytherapy Superior to Anti-VEGF in Treating Age-Related Macular Degeneration?

July 21, 2020

Article

Epimacular brachytherapy does not reduce the number of ranibizumab injections required by patients with chronic, active neovascular age-related macular degeneration (ARMD), and it is associated with worse visual acuity compared with anti-vascular endothelial growth factor (VEGF) treatment alone, according to a study published in JAMA Ophthalmology.

Does Facedown Position Improve Macular Hole Surgery Outcomes?

July 16, 2020

Article

Facedown positioning following surgery is not more likely to close large (≥400 mcm) macular holes compared with seating faced forward, according to a study published in JAMA Ophthalmology. However, visual acuity outcomes may be superior when patients are placed facedown after surgery.

How Does Obesity Affect Retinochoroidal Vasculature?

July 15, 2020

Article

Subclinical changes in retinochoroidal vasculature occur in obese individuals, according to a study published in PLoS ONE. Surgical intervention, such as bariatric surgery, may have a favorable outcome on the choroidal thickness in these patients’ eyes.

Study Finds Racial, Socioeconomic Disparities in Uveal Melanoma Treatment

July 08, 2020

Article

Racial, ethnic, and socioeconomic status disparities exist in uveal melanoma treatment and survival, according to a study published in JAMA Ophthalmology.

Indoor Humidity, Particulate Matter Associated With Worse Dry Eye Symptoms

July 07, 2020

Article

Increased particulate matter exposure is associated with worse dry eye metrics, after adjusting for humidity, according to a study published in JAMA Ophthalmology. The study also found that humidity is positively associated with dry eye metrics, potentially due to the fact that higher humidity increases microbial growth and subsequent particulate matter size and mass.

Can Red Light Exposure Improve Eyesight?

July 02, 2020

Article

Looking into a deep red light for 3 minutes each day may significantly improve declining eyesight, according to a study published in Journals of Gerontology.